389 related articles for article (PubMed ID: 26255991)
61. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome.
Güdücü N; Görmüş U; Kutay SS; Kavak ZN; Dünder I
Gynecol Endocrinol; 2014 Aug; 30(8):557-60. PubMed ID: 24819314
[TBL] [Abstract][Full Text] [Related]
62. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
[TBL] [Abstract][Full Text] [Related]
63. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.
Sahin FK; Sahin SB; Ural UM; Cure MC; Senturk S; Tekin YB; Balik G; Cure E; Yuce S; Kirbas A
Bosn J Basic Med Sci; 2015 Jul; 15(3):57-63. PubMed ID: 26295295
[TBL] [Abstract][Full Text] [Related]
64. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
[TBL] [Abstract][Full Text] [Related]
65. Serum LBP Is Associated with Insulin Resistance in Women with PCOS.
Zhu Q; Zhou H; Zhang A; Gao R; Yang S; Zhao C; Wang Y; Hu J; Goswami R; Gong L; Li Q
PLoS One; 2016; 11(1):e0145337. PubMed ID: 26799617
[TBL] [Abstract][Full Text] [Related]
66. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.
Bacopoulou F; Kolias E; Efthymiou V; Antonopoulos CN; Charmandari E
Eur J Clin Invest; 2017 Oct; 47(10):746-755. PubMed ID: 28795765
[TBL] [Abstract][Full Text] [Related]
67. Prevalence and degree of insulin resistance in Chinese Han women with PCOS: Results from euglycemic-hyperinsulinemic clamps.
Li W; Chen Q; Xie Y; Hu J; Yang S; Lin M
Clin Endocrinol (Oxf); 2019 Jan; 90(1):138-144. PubMed ID: 30229990
[TBL] [Abstract][Full Text] [Related]
68. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
Güneş M; Bukan N
Gynecol Endocrinol; 2015; 31(11):903-6. PubMed ID: 26291814
[TBL] [Abstract][Full Text] [Related]
69. Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome.
Tao T; Li S; Zhao A; Zhang Y; Liu W
Eur J Endocrinol; 2012 Nov; 167(5):705-13. PubMed ID: 22945299
[TBL] [Abstract][Full Text] [Related]
70. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
71. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
[TBL] [Abstract][Full Text] [Related]
72. Biomarkers and insulin sensitivity in women with Polycystic Ovary Syndrome: Characteristics and predictive capacity.
Cassar S; Teede HJ; Harrison CL; Joham AE; Moran LJ; Stepto NK
Clin Endocrinol (Oxf); 2015 Jul; 83(1):50-8. PubMed ID: 25262763
[TBL] [Abstract][Full Text] [Related]
73. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
[TBL] [Abstract][Full Text] [Related]
74. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.
Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M
Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546
[TBL] [Abstract][Full Text] [Related]
75. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
[TBL] [Abstract][Full Text] [Related]
76. Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome.
Lai Y; Chen J; Li L; Yin J; He J; Yang M; Jia Y; Liu D; Liu H; Liao Y; Yang G
Sci Rep; 2016 May; 6():25934. PubMed ID: 27180914
[TBL] [Abstract][Full Text] [Related]
77. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
Coviello AD; Legro RS; Dunaif A
J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280
[TBL] [Abstract][Full Text] [Related]
78. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.
Santos BR; Lecke SB; Spritzer PM
PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285
[TBL] [Abstract][Full Text] [Related]
79. Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome.
Mu L; Li R; Lai Y; Zhao Y; Qiao J
J Endocrinol Invest; 2019 May; 42(5):541-548. PubMed ID: 30206805
[TBL] [Abstract][Full Text] [Related]
80. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.
He C; Lin Z; Robb SW; Ezeamama AE
Nutrients; 2015 Jun; 7(6):4555-77. PubMed ID: 26061015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
